Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors

用贝伐单抗治疗胃肠道癌细胞可通过 PI3K-AKT、HIF-1α 和 VEGF 受体激活涉及端粒酶催化亚基 hTERT 的 VEGF 自身调节机制